Revenue Performance - Tenon Medical, Inc. reported unaudited revenue for Q4 2025 of $1.45 to $1.48 million, representing a 90% year-over-year increase compared to Q4 2024[4] - For the fiscal year 2025, the company reported unaudited revenue of $3.91 to $3.94 million, reflecting a 20% year-over-year increase compared to fiscal year 2024[4] Future Financial Reporting - The company plans to release detailed financial results for Q4 and full year 2025 on March 19, 2026, after market close[5]

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ____________________ FORM 10-Q ________________________ (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 1-36900 MADISON SQUARE GARDEN SPORTS CORP. (Exact name of regist ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-37651 Atlassian Corporation (Exact name of Registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) (I.R.S. Emplo ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-33387 GSI Technology, Inc. (Exact name of registrant as specified in its charter) (State or other jurisdiction of inco ...

Washington, D.C. 20549 SECURITIES AND EXCHANGE COMMISSION FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the year ended December 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Table of Contents UNITED STATES Commission file number: 001-10989 Ventas, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 61-1055020 (State or Other Jurisdictio ...

FORM 10-Q (Mark One) Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 STERIS plc (Exact name of registrant as specified in its charter) Ireland 98-1455064 (State or other jurisdiction of incorporation or organization) 70 Sir John Rogerson's Quay, Dublin 2, Ireland D02 R296 (Address of principal executive offices) (Zip code) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2025 or ☐ ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 6, 2026 FS CREDIT OPPORTUNITIES CORP. Maryland 811-22802 46-1882356 (State or other jurisdiction of incorporation) 3025 JFK Boulevard, OFC 500 Philadelphia, Pennsylvania 19104 (Address of principal executive offices) (Zip Code) (Commission File Number) (I.R.S. Employer Identification N ...

Financial Position - Accounts receivable, net of the allowance for uncollectible accounts, were $36.8 million as of December 31, 2025, down from $37.9 million as of June 30, 2025[45]. - The allowance for credit losses increased to $15.48 million as of December 31, 2025, compared to $11.15 million as of December 31, 2024[46]. - Total finance receivables amounted to $11.46 million as of December 31, 2025, with a projected total of $9.33 million to be collected after accounting for interest and uncollectible receivables[49]. - Total lease liabilities were $9.22 million as of December 31, 2025, compared to $9.93 million as of June 30, 2025[51]. - As of December 31, 2025, total accrued expenses amounted to $25.3 million, an increase from $19.7 million as of June 30, 2025[69]. - The company has total outstanding borrowings of $38.0 million as of December 31, 2025, with a potential increase in interest expense of $0.4 million per year if the SOFR Rate increases by 100 basis points[185]. Revenue and Growth - The Company recognized $4.6 million in revenue from its device rental program for the six months ended December 31, 2025, slightly up from $4.5 million in the same period of 2024[53]. - Total revenues for the three months ended December 31, 2025, were $78.712 million, a 6.7% increase from $73.722 million in the same period of 2024[87]. - Subscription and transaction fees for the six months ended December 31, 2025, totaled $140.002 million, up from $128.877 million in 2024, reflecting an 8.5% growth[87]. - The Company recognized total lease revenues of $4.977 million for the six months ended December 31, 2025, down from $5.442 million in 2024[88]. - Revenue for the three months ended December 31, 2025, was $78,712,000, an increase from $73,722,000 in 2024, while revenue for the six months ended December 31, 2025, was $159,565,000 compared to $144,558,000 in 2024[112]. Expenses and Losses - Segment expenses for the three months ended December 31, 2025, totaled $78,782,000, up from $73,722,000 in 2024[112]. - For the three months ended December 31, 2025, the company reported a net loss of $70,000 compared to a net income of $4,974,000 for the same period in 2024[104]. - Basic and diluted earnings per share for the six months ended December 31, 2025, were both $(0.02), down from $0.11 in 2024[104]. - The income tax provision for the three months ended December 31, 2025, was $1.1 million, compared to $0.4 million in the same period of 2024[101]. Acquisitions - The Company acquired SB Software for approximately $11.4 million, enhancing operational capabilities and market reach in Europe[75]. - The acquisition of SB Software included $10.0 million in cash and $1.4 million in contingent consideration based on revenue growth targets[75]. - Total identifiable net assets acquired from SB Software were valued at $3.6 million, with goodwill of $7.8 million recognized[78]. - The Company acquired Cheq for $4.5 million, including $1.1 million in accounts payable, to expand into sports, entertainment, and restaurant sectors[81]. - The fair value of identifiable net assets acquired from Cheq was $2.458 million, with $2 million recognized as goodwill[83][84]. Financing and Credit Facilities - The 2025 Credit Facility had a total of $37.71 million as of December 31, 2025, down from $38.66 million as of June 30, 2025[55]. - The 2025 Credit Facility includes a $40 million secured term loan, a $30 million secured revolving credit facility, and a $30 million delayed draw term loan facility[57]. - Proceeds from the 2025 Term Loan Facility were used to repay $37.3 million in borrowings under the 2022 Amended JPMorgan Credit Facility[66]. - The weighted average interest rate for the 2025 Credit Facility is approximately 7.16%, with interest rates ranging from 1.75% to 3.50% based on the type of loan[60]. - The Company has not borrowed against the 2025 Revolving Facility or the Delayed Draw Term Loan Facility as of the reporting date[58]. - The Company was in compliance with its financial covenants for the 2025 Credit Facility as of December 31, 2025, maintaining a total leverage ratio of not more than 3.50 to 1.00[63]. Accounting and Compliance - The Company is currently assessing the impact of new accounting standards on its consolidated financial statements and disclosures, including ASU 2023-09 and ASU 2024-03[40][41]. - The Company’s finance receivables agreements are predominantly classified as non-cancellable sixty-month sales-type leases[47]. - The company has not accrued for any legal proceedings as there are currently no loss exposures considered probable and reasonably estimable[108]. - The total expense recognized for related party transactions was $0.1 million for the six months ended December 31, 2025, and 2024[109]. - The company has approximately 4.6 million potentially anti-dilutive shares excluded from the calculation of diluted earnings per share for the six months ended December 31, 2025[104]. Cash Management - Cash paid for operating lease liabilities was $1.52 million for the six months ended December 31, 2025, compared to $1.06 million for the same period in 2024[51]. - The company invests excess cash in money market funds, which are not held for trading or speculative purposes, indicating a low exposure to interest rate changes[186]. Contractual Obligations - The estimated fees to be recognized in future periods related to unsatisfied performance obligations total $5.647 million as of December 31, 2025[93]. - Contract assets increased to $4.3 million as of December 31, 2025, compared to $3.3 million as of June 30, 2025[89]. - Deferred revenue at the end of the period was $3.645 million for the three months ended December 31, 2025, compared to $1.356 million in 2024[91].

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended January 2, 2026 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission File Number 000-17781 Gen Digital Inc. (Exact name of the registrant as specified in its charter) | Delaware | | | | 77-0181864 | | --- | --- | ...

Revenue Sources - Approximately 32% of total consolidated revenues were generated from U.S. government agencies for the years ended December 31, 2025, 2024, and 2023, respectively [25]. - The Medicaid business includes managed care alternatives through public-funded healthcare programs, covering various services in 17 states and Puerto Rico [41]. - Approximately 53.5% of premium revenue and 18.7% of medical membership were subject to minimum MLR regulations for the year ended December 31, 2025 [99]. - Approximately 54.2% of premium revenue and 18.4% of medical membership were subject to minimum MLR regulations for the year ended December 31, 2024 [99]. Health Benefits and Services - The Health Benefits segment offers a comprehensive suite of health plans and services, with key drivers including membership levels, premium pricing, and medical cost trends [27]. - CarelonRx, which includes pharmacy services, was enhanced by the acquisition of Paragon Healthcare, Inc. in March 2024, contributing to affordability and outcomes for members [27]. - The Carelon Services segment integrates physical, behavioral, pharmacy, and social-care capabilities, targeting chronic and complex populations [28]. - Carelon integrates services to deliver whole health affordably, powered by analytics [38]. - Carelon Health provides value-based solutions and comprehensive care management services, including home health and behavioral health management [47]. - A comprehensive behavioral health case management program supports members with various conditions, promoting access to appropriate treatment and community resources [71]. - The company has implemented a "Food as Medicine" strategy across multiple business lines to address food and nutrition insecurity among its members [73]. - The company focuses on care coordination based on nationally recognized criteria to improve inpatient and outpatient care, aiming to reduce preventable hospital admissions [75]. - The company has developed partnerships with network physicians and hospitals to enhance healthcare quality and social impact services, recognized by NCQA accreditation [76]. - The company utilizes HEDIS measures to improve care for chronic diseases and reduce healthcare disparities, including diabetes and heart disease management [77]. Market Position and Competition - The managed care industry is highly competitive, with intense competition driven by aggressive marketing, pricing, and new strategic alliances [43]. - The company leverages its BCBS brand for greater recognition and competitive positioning, being the largest participant in its branded markets [45]. - Pricing strategies are based on predictive modeling and proprietary research, aiming for growth through market expansions and regulatory changes [46]. - CarelonRx pricing is competitive, utilizing discounts off average wholesale prices and rebate projections to maintain market competitiveness [54]. Regulatory Environment - The Consolidated Appropriations Act of 2023 allows states to begin removing ineligible beneficiaries from Medicaid programs, impacting enrollment dynamics [86]. - The Inflation Reduction Act of 2022 includes provisions that may increase Public Exchange coverage premiums after enhanced PTCs expire on December 31, 2025 [88]. - The ACA has introduced new risks and regulatory challenges, significantly impacting the company's business model and product administration [96]. - The company anticipates ongoing regulatory guidance from CMS regarding Medicare ratings and quality bonus payments, which could affect financial recoveries [97]. - The company is required to comply with various BCBSA license agreements, including maintaining at least 80% of annual combined local net revenue under the BCBS names and marks [80]. Financial Performance - Net cash provided by operating activities decreased to $4,290 million in 2025 from $5,808 million in 2024, a decline of $1,518 million [371]. - Total sources of cash fell to $6,458 million in 2025, down from $12,815 million in 2024, a decrease of $6,357 million [371]. - Issuances of short- and long-term debt decreased significantly to $629 million in 2025 from $6,200 million in 2024, a drop of $5,571 million [371]. - The company repurchased and retired $2,605 million of common stock in 2025, compared to $2,900 million in 2024, a reduction of $295 million [371]. - Cash dividends paid increased slightly to $1,529 million in 2025 from $1,508 million in 2024 [371]. - The net increase in cash and cash equivalents was $1,203 million in 2025, compared to an increase of $1,828 million in 2024 [371]. - The company reported a total of $69 million from sales, maturities, calls, and redemptions of investments in 2025, down from $586 million in 2024 [371]. - The company had no purchases of investments in 2025, while it had $2,700 million in 2024 [371]. - Other sources of cash, net, amounted to $1,391 million in 2025, with no contributions in 2024 [371]. - The effect of foreign exchange rates on cash and cash equivalents was a decrease of $5 million in 2025 [371]. - As of December 31, 2025, consolidated cash, cash equivalents, and investments totaled $37,236 million, an increase of $1,520 million from December 31, 2024 [374]. - The debt-to-capital ratio was 42.1% as of December 31, 2025, down from 43.0% in 2024, indicating improved leverage [378]. - The company expects to receive approximately $2,100 million in dividends from subsidiaries during 2026, compared to $2,543 million received in 2025 [386]. - Future debt and estimated interest payments total $54,160 million, with $2,490 million due within the next twelve months [395]. - The company has a remaining Board authorization of $6,695 million for common stock repurchases as of December 31, 2025 [392]. - The 5-Year Facility was amended to increase available credit from $4,000 million to $5,000 million and extend the maturity date to September 2030 [381]. - Cash disbursements are primarily driven by claims payments, administrative expenses, and capital expenditures, with adequate liquidity expected from cash on hand and credit facilities [388]. - The company maintains a commercial paper program of up to $5,000 million, with no amounts outstanding as of December 31, 2025 [384]. - Future estimated payments for operating leases are $743 million, with $159 million due within the next twelve months [395]. - The company is in compliance with all debt covenants under the 5-Year Facility as of December 31, 2025 [382]. Employee and Culture - The company invested an average of approximately 26 hours of training and development per associate in 2025 [125]. - The company’s employee population consisted of approximately 97,100 individuals as of December 31, 2025, with 99% employed full-time [118]. - The company completed a gender and race pay equity review in 2025, finding female associates earn more than 99 cents for every dollar earned by similarly situated male associates [124]. - The company’s culture and engagement initiatives include over 20% of the U.S. workforce participating in Business Resource Groups in 2025 [122]. Transparency and Compliance - The Health Plan Transparency Rule requires the company to disclose detailed pricing information on a monthly basis, starting from July 2022 [114].